BSG and chronic myelogenous leukemia, BCR-ABL1 positive: Although a direct relationship between CD147 and metabolic regulation in CML are still to be explored, a recent study “in vivo” investigated the antitumor efficacy of a novel CD147-targeting antibody (h4 # 147D) in three xenograft mouse models that housed chemo-resistant human cell lines from different cancers.